Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
153.95
+1.04 (0.68%)
At close: Feb 5, 2026, 4:00 PM EST
153.85
-0.10 (-0.06%)
Pre-market: Feb 6, 2026, 8:37 AM EST

Novartis AG Revenue

In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth. Novartis AG had revenue of $524.00M in the quarter ending December 31, 2025, with 29.38% growth.

Revenue (ttm)
$56.67B
Revenue Growth
+9.57%
P/S Ratio
5.16
Revenue / Employee
$752,973
Employees
75,267
Market Cap
292.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202556.67B4.95B9.57%
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 201948.68B2.58B5.59%
Dec 31, 201846.10B2.70B6.21%
Dec 31, 201743.40B-6.03B-12.20%
Dec 31, 201649.44B-951.00M-1.89%
Dec 31, 201550.39B-3.25B-6.05%
Dec 31, 201453.63B918.00M1.74%
Dec 31, 201352.72B745.00M1.43%
Dec 31, 201251.97B-7.40B-12.47%
Dec 31, 201159.38B7.81B15.15%
Dec 31, 201051.56B6.46B14.32%
Dec 31, 200945.10B2.52B5.92%
Dec 31, 200842.58B3.64B9.34%
Dec 31, 200738.95B3.84B10.94%
Dec 31, 200635.11B5.35B17.99%
Dec 31, 200529.75B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson94.19B
Merck & Co.65.01B
Pfizer62.58B
AbbVie61.16B
AstraZeneca58.13B
Sanofi54.85B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
Revenue Rankings